[Complex assessment of treatment effectiveness in cardiopulmonary failure using digoxin controlled by determining its concentration in the blood plasma].
Combined therapy including digoxin improves the patients' clinical status and hemodynamics producing a normalizing effect on cardiac ejection, raises myocardial contractility, reduces pulmonary hypertension. The use of digoxin improves pulmonary metabolic function, lowers a degree of hypoxia. Combined evaluation of clinicofunctional data with regard for the dynamic determination of digoxin plasma concentration allows more effective glycoside therapy preventing the development of intoxication and resulting in a noticeable therapeutic effect. The use of digoxin is effective for initial and advanced stages of cardiopulmonary incompetence.
L D
LD
Sidorova
G F
GF
Arkhipova
L M
LM
Kudelia
I I
II
Pavlova
V K
VK
Petrenko
D000328:Adult; D001991:Bronchitis / Q000150:complications; D002908:Chronic Disease; D004077:Digoxin / Q000097:blood / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D006333:Heart Failure / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008875:Middle Aged; D012131:Respiratory Insufficiency / Q000097:blood / Q000188:drug therapy* / Q000209:etiology
D004077:Digoxin
Kompleksnaia otsenka éffektivnosti lecheniia legochno-serdechnoĭ nedostatochnosti digoksinom pod kontrolem opredeleniia ego kontsentratsii v plazme krovi.